Warner Bros. Discovery, Inc.
PYRROLOPYRIMIDINE COMPOUND AND USE THEREOF

Last updated:

Abstract:

The present invention relates to a pyrrolopyrimidine compound used as a JAK inhibitor, and the use thereof in the preparation of a drug for treating a JAK1- and/or JAK2-associated disease, and in specifically relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof. ##STR00001##

Status:
Application
Type:

Utility

Filling date:

5 Jun 2020

Issue date:

21 Jul 2022